glp 1 for liver health Current Status of Glucagon-like Peptide-1 Receptor Agonists in Metabolic Dysfunction-associated Steatotic Disease: A Clinical Perspective Effects of GLP-1 receptor agonists

What makes Orforglipron 3 mg, 12 mg, and 36 mg Tablets convenient for daily use

As a dual GIP/GLP-1 receptor agonist, tirzepatide has demonstrated superior weight loss outcomes in clinical trials compared to semaglutide alonea topic we explore in depth in our Tirzepatide vs

Red flags include severe bloating with a swollen, hard belly, inability to pass gas, and no bowel movements [13]

1,2 Initially developed as antidiabetic treatments, GLP-1 RAs and, more recently, dual glucose-dependent insulinotropic polypeptide (GIP)/GLP-1 receptor agonists have demonstrated favourable metabolic outcomes with significant and sustainable weight loss in large randomised controlled trials (RCTs) and real-world studies

Contact us today by phone or book an appointment online

What's New with GLP-1 Coverage in 2026 While GLP-1 agonists have been around for over a decade now, they've seen a big jump in popularity in the last couple of years